Atlas Trials

A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Enicepatide in Generally Healthy Adult Chinese Participants

Clinical trial NCT07626515 · RECRUITING

Trial details

NCT number
NCT07626515
Sponsor
Hoffmann-La Roche
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Participants
Start date
2026-07-02
Primary completion
2027-05-14
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.